Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom

We developed a dynamic compartmental model to assess the impact of HPV Universal Mass Vaccination (UMV) with Cervarix™, which offers protection against HPV16/18 and cross-protection against other cancer-causing types, using up-to-date efficacy data. Analyses were performed in the UK because of the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Effelterre, Thierry P, Hogea, Cosmina, Taylor, Sylvia M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155626/
https://www.ncbi.nlm.nih.gov/pubmed/26090944
http://dx.doi.org/10.1080/21645515.2015.1054584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155626/
https://www.ncbi.nlm.nih.gov/pubmed/26090944
http://dx.doi.org/10.1080/21645515.2015.1054584

Ejemplares similares